Author:
Saviozzi Silvia,Cordero Francesca,Iacono Marco Lo,Novello Silvia,Giorgio Scagliotti V,Calogero Raffaele A
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference47 articles.
1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, American Cancer S: Cancer statistics, 2004. CA: a Cancer Journal for Clinicians. 2004, 54 (1): 8-29.
2. Mather D, Sullivan SD, Parasuraman TV: Beyond survival: economic analyses of chemotherapy in advanced inoperable NSCLC. Oncology (Huntingt). 1998, 12: 199-209.
3. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH, Eastern Cooperative Oncology G: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.[see comment]. New England Journal of Medicine. 2002, 346 (2): 92-98. 10.1056/NEJMoa011954.
4. Bepler G, Sharma S, Cantor A, Gautam A, Haura E, Simon G, Sharma A, Sommers E, Robinson L: RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. Journal of Clinical Oncology. 2004, 22 (10): 1878-1885. 10.1200/JCO.2004.12.002.
5. Rosell R, Felip E, Taron M, Majo J, Mendez P, Sanchez-Ronco M, Queralt C, Sanchez JJ, Maestre J: Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery. Clinical Cancer Research. 2004, 10 (12 Pt 2): 4215s-4219s. 10.1158/1078-0432.CCR-040006.
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献